Category: Healthcare
-
Oral Insulin Market Set to Scale from $300.00 Million to $1.86 Billion by 2035
The Oral Insulin Market grows from $300.00 Million in 2025 to $1.86 Billion by 2035 at a 20.0% CAGR, driven by patient preference for needle free therapy.
-
Longevity Clinic Market Set to Scale from $6.80 Billion to $21.50 Billion by 2035
The Longevity Clinic Market is projected to grow from $6.80 Billion in 2025 to $21.50 Billion by 2035 at a 12.2 percent CAGR, led by ageing and healthspan demand.
-
Asia Pacific Autoclave Equipment Market Set to Scale from $1.09 Billion to $2.42 Billion by 2035
The Asia Pacific Autoclave Equipment market grows from $1.09 Billion in 2025 to $2.42 Billion by 2035 at an 8.3% CAGR, driven by hospital sterile processing build-out and aerospace composite capacity.
-
Lipid Nanoparticle Market Set to Scale from $1.00 Billion to $3.55 Billion by 2035
The Lipid Nanoparticle market is projected to grow from $1.00 Billion in 2025 to $3.55 Billion by 2035 at a 13.5% CAGR, driven by mRNA pipeline growth and gene editing delivery.
-
Actinium-225 Market Set to Scale from $380.00 Million to $4.15 Billion by 2035
The Actinium-225 market is projected to grow from $380.00 Million in 2025 to $4.15 Billion by 2035 at a 27.0% CAGR, led by the targeted alpha therapy pipeline.
-
Theranostics Market Set to Scale from $3.60 Billion to $12.01 Billion by 2035
The Theranostics Market is projected to grow from $3.60 Billion in 2025 to $12.01 Billion by 2035 at a 12.8% CAGR, driven by radioligand therapy approvals and precision oncology.
-
Xenotransplantation Market Set to Scale from $380.00 Million to $1.83 Billion by 2035
The Xenotransplantation Market is projected to grow from $380.00 Million in 2025 to $1.83 Billion by 2035 at a 17.0% CAGR, driven by the donor organ shortage and multi-gene editing of donor pigs.
-
Pen Injector Market Set to Scale from $8.20 Billion to $19.24 Billion by 2035
The Pen Injector Market is projected to grow from $8.20 billion in 2025 to $19.24 billion by 2035 at an 8.9% CAGR, driven by GLP-1 and obesity drug uptake.
-
Radioligand Therapy Market Set to Scale from $3.20 Billion to $18.22 Billion by 2035
The Radioligand Therapy Market is projected to grow from $3.20 Billion in 2025 to $18.22 Billion by 2035 at a 19.0% CAGR, driven by PSMA prostate cancer uptake, the alpha-emitter pipeline and theranostic patient selection.
-
AI Medical Scribe Market Set to Scale from $600.00 Million to $5.16 Billion by 2035
The AI Medical Scribe Market is projected to grow from $600.00 Million in 2025 to $5.16 Billion by 2035 at a 24.0% CAGR, driven by clinician burnout, better language models and EHR integration.